References
- Furue M, editor. Japanese Dermatological Association criteria for the diagnosis of atopic dermatitis, 2008 edition. Japan: The Japanese Dermatological Association; 2009. p. 1515–1534.
- Sowden JM, Berth-Jones J, Ross JS, Montley RJ, Marks R, Finlay AY, Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis. Lancet. 1991;338:137–140.
- Van Joost T, Heule F, Korstanje M, Van Den Broek MJTB, Stenveld HJ, Van Vloten WA. Cyclosporin in atopic dermatitis: A multicentre placebo-controlled study. Br J Dermatol. 1994;130:634–640.
- Zonneveld IM, De Rie MA, Beljaards RC, Van Der Rhee HJ, Wuite J, Zeegelaar J, The long-term safety and efficacy of cyclosporin in severe refractory atopic dermatitis: A comparison of two dosage regimens. Br J Dermatol. 1996;135(suppl 48):15–20.
- Berth-Jones J, Graham-Brown RA, Marks R, Camp RDR, English JSC, Freeman K, Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis. Br J Dermatol. 1997;136:76–81.
- Czech W, Brautigam M, Weidinger G, Scopf E, and ADOPT study group. A body-weight-independent dosing regimen of cyclosporine microemulsion is effective in severe atopic dermatitis and improves the quality of life. J Am Acad Dermatol. 2000;42:653–659.
- Schmitt J, Schakel K, Schmitt N, Meurer M. Systemic treatment of severe atopic eczema: A systematic review. Acta Derm Venerol. 2007;87:100–111.
- Hashizume H, Ito T, Yagi H, Takikawa M, Kageyama H, Furukawa F, Efficacy and safety for pre-prandial versus post-prandial administration of low-dose cyclosporin microemulsion (Neoral) in patients with psoriasis vulgaris. J Dermatol. 2007;34:430–434.
- Umezawa Y, Mabuchi T, Ozawa A. Pre-prandial vs. post-prandial pharmacokinetics of cyclosporine in patients with psoriasis. Int J Dermatol. 2007;46:880–882.
- Brandt C, Pavlovic V, Radbruch A, Worm M, Baumgrass R. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy. 2009;64:1588–1596.
- Kusaba T, Konno Y, Hatta S, Fujino T, Yasuda T, Miura H, More stable and reliable pharmacokinetics with pre-prandial administration of cyclosporine compared with post-prandial administration in patients with refractory nephrotic syndrome. Pharmacotherapy. 2005;25:52–58.
- Shirai S, Yasuda T, Tsuchida H, Kuboshima S, Konno Y, Shima Y, Pre-prandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome. Clin Exp Nephrol. 2009;13:123–129.
- Naito M, Takei T, Eguchi A, Uchida K, Tsuchiya K, Nitta K. Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome. Internal Med. 2008;47:1567–1572.